Thai Special Committee's Inspection of Chinese Vape Factories Raises Questions

Regulations by 2FIRSTS.ai
Apr.18.2024
Thai Special Committee's Inspection of Chinese Vape Factories Raises Questions
Thai Parliament approves budget for committee to visit China e-cigarette factories, sparking concerns over potential conflicts of interest.

According to newsdirectory3 on April 18th, the Thai House of Representatives has approved a budget to support a special committee to visit e-cigarette production factories in China. The Tobacco Control Network has expressed skepticism about the approval of the budget for this committee.

 

On April 17, 2024, Wanchat Suphachatra, Director of the Smoke-Free Social Health Expert Network in Thailand and former President of the World Medical Association, revealed that the committee is considering studying laws and measures to control and regulate e-cigarettes in Thailand, with plans to visit manufacturing factories and the e-cigarette market in China. This action has raised questions about the committee's fulfillment of its duties, as e-cigarettes are illegal products in Thailand.

 

The committee should play a role in diligently supervising and enforcing laws. Instead, it goes on factory visits as if to promote sales and production in Thailand. This will damage the image of the committee and parliament in Thailand.

 

Naowarat Charoenkha, director of the Thailand Health Promotion Institute, said that the committee must address the question of what benefits visiting e-cigarette production and distribution research would bring. This is because such visits are similar to the practices of international tobacco companies, which often lead to politicians, government officials, and media going abroad to visit factories to promote the sales of these products.

 

The Tobacco Control Network has taken note of the committee's work, which has already been mentioned. There are also individuals involved in the committee who have ties to international tobacco companies, which violates Article 5.3 of the World Health Organization Framework Convention on Tobacco Control, which prohibits individuals with shared interests with tobacco companies from participating in developing policies to control tobacco products. Therefore, visiting e-cigarette factories in China reflects the irregularity of the committee's operations, which is highly inappropriate and goes against the principles of tobacco control set by the World Health Organization.

 

Wit Kasemsap, Director of the Tobacco Control Research and Knowledge Management Center (CRC) at Ramathibodi University's Medical School in Thailand, has stated that the committee should research the enforcement procedures of various countries regarding e-cigarettes. If the committee wishes to learn more information, they should consult with the Ministry of Health or the Department of Digital Affairs, and could even invite representatives from the World Health Organization to provide information.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
According to Chinese patent records, a “nicotine tooth patch” application filed by China Tobacco Hubei Industrial Corporation (CTHB) and Hubei Xinye Tobacco Sheet Development Co., Ltd. was published on May 19, 2026. The filing proposes a nicotine gel patch that adheres to the tooth surface, especially the lingual side, to reduce displacement, foreign-body sensation, and accidental swallowing risks associated with existing oral nicotine products.
Jun.10
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Haypp Group reported a 40% year-on-year increase in nicotine pouch volumes in the first quarter of 2026, with U.S. and U.K. volumes rising 123% and 102%, respectively. Haypp says around 97% of its consumer traffic is organic and that its Media & Insights business provides brand owners with on-site visibility, trial activation and consumer intelligence. For international tobacco companies, Haypp may be both a growth partner for modern oral products and a new source of channel leverage.
Special Report
May.22
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
New Canadian research shows that 34.8% of people aged 17 to 27 have tried nicotine pouches, up more than fourfold from 7.6% in 2022. The findings come as Conservative politicians, Alberta’s government and the tobacco industry push Ottawa to relax current restrictions on pouch sales.
Jun.12
Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
mperial Brands has launched blu MAX 6000 in the UK, positioning the product as a higher-puff vape kit with longer-lasting use and replaceable pod+refill options. The device uses a 2ml+10ml click-on box format, with starter kits priced at £10.99 (approximately $14) and replacement pod+refill packs priced at £7.99 (approximately $10).
Market
May.19
Haypp Report: Women Emerge as a Key Growth Driver in the UK Nicotine Pouch Market
Haypp Report: Women Emerge as a Key Growth Driver in the UK Nicotine Pouch Market
According to Haypp’s 2026 UK Nicotine Report, women are a key growth driver in the UK nicotine pouch market. Overall sales for Haypp and Northerner rose 60% year‑on‑year in 2025, but purchases by women surged 202%, versus 25% for men. Women’s share of consumers jumped from 22% to 40%. The report attributes this to discretion, perceived health benefits, and more gender‑neutral product positioning, suggesting future growth will come from a broader range of adult nicotine users.
Jul.01